REFERENCES
- Nassberger L, Johansson AC, Bjorck S, Sjoholm AG. Antibodies to neutrophil granulocyte myeloperoxidase and elastase: Autoimmune responses in glomerulonephritis due to hydralazine treatment. J Intern Med. 1991;229(3):261–265.
- Peacock A, Weatherall D. Hydralazine-induced necrotizing vasculitis. BMJ. 1981;282:1121–1122.
- Almroth G, Enestrom S, Hed J, Samuelsson I, Sjostrom P. Autoantibodies to leucocyte antigens in hydralazine-associated nephritis. J Intern Med. 1992;231(1):37–42.
- Cambridge G, Wallace H, Bernstein RM, Leaker B. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol. 1994;33(2):109–114.
- Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: Prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000;43(2):405–413.
- Short AK, Lockwood CM. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. Q J Med. 1995;88:775–783.
- Savige J, Davies D, Falk RJ, Jennette CJ, Wiik A. Antineutrophil cytoplasmatic antibodies and associated diseases: A review of the clinical and laboratory features. Kidney International. 2000;57:846–862.
- Ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug- induced vasculitis. Ann Pharmacother. 2002;36:130–147.
- Hess E. Drug-induced lupus. N Engl J Med. 1988;318:1460.
- Speirs C, Fielder AH, Chapel H, Davey NJ, Batchelor JR. Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus. Lancet. 1989;1(8644):922–924.
- Batchelor JR, Welsh KI, Tinoco RM, Hydralazine-induced systemic lupus erythematosus: Influence of HLA-DR and sex on susceptibility. Lancet. 1980;1(8178):1107–1109.
- Ihle BU, Whitworth JA, Dowling JP, Kincaid-Smith P. Hydralazine-associated glomerulonephritis. Clin Nephrol. 1984;22:230–238.
- Merkel PA. Drugs associated with vasculitis. Curr Opin Rheumatol. 1998;10(1):45–50.
- Nassberger L, Sjoholm AG, Jonsson H, Autoantibodies against netrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol. 1990;81:380.
- Ohtani H, Wakui H, Komatsuda A, Differences between myeloperoxidase-specific and nonspecific P‐ANCA-associated renal disease. Ren Fail. 2007;29(2):183–187.
- Burlingame RW, Rubin RL. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest. 1991;88(2):680–690.